TRV:NYSE

The stock is trading at $303.19, just below its 52‑week high of $313.12 and comfortably above the 20‑day SMA of $303.24, with the 50‑day and 200‑day SMAs also trailing lower, signaling a bullish trend. However, the MACD histogram is negative (-0.60) and the MACD signal is bearish, while the RSI sits at a neutral 54.5, indicating short‑term momentum pressure near the $313 resistance level and a support cushion around $291.
Fundamentally, TRV appears markedly undervalued: its trailing P/E of 11.0 is well below the industry average of 17.4, and the DCF‑derived fair value of $859 suggests a substantial upside gap. The company delivers a solid ROE of 20.7%, a healthy operating margin of 25.9%, and a sustainable dividend yield of 1.45% with a modest payout ratio of 16%. Cash holdings of $6.4 B comfortably exceed debt of $9.5 B, and free cash flow remains robust.
Risk‑wise, TRV benefits from a low beta of 0.44 and moderate 30‑day volatility (17.5%). The insurance sector carries medium regulatory and sector risk, but the company’s U.S. focus limits geographic exposure, and its large market cap and stable volume mitigate liquidity concerns.